Discrepancy between the Actions of Glucagon-like Peptide-1 Receptor Ligands in the Protection of the Heart against Ischemia Reperfusion Injury

Tirzepatide is a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist and a promising therapy for type 2 diabetes mellitus (T2DM). GLP-1 is an incretin hormone with therapeutic potential beyond type 2 diabetes mellitus. However, GLP-1 is rapidl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismaeil, Ali, Babiker, Fawzi, Al-Sabah, Suleiman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228343/
https://www.ncbi.nlm.nih.gov/pubmed/35745639
http://dx.doi.org/10.3390/ph15060720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228343/
https://www.ncbi.nlm.nih.gov/pubmed/35745639
http://dx.doi.org/10.3390/ph15060720

Ejemplares similares